In the subgroup analysis by tumor type, the LEP 2548A (or 19G) allele was significantly associated with risk of prostate cancer (AA vs. AG+GG: OR=1.26, 95%CI=1.05-1.51) but not with cancers of the breasts and colorectal or other specified cancers. This evidence concerns the gene LEP and breast carcinoma.